EOLS · Evolus Inc. Common Stock
View on chartInsiders & Stakes
| Alphaeon 1 LLC | ▼ Sell | Open Market | 4,214,871 Shares held | 2/17/2023 | View profile |
| Medytox Inc. 10% Owner | ▼ Sell | Open Market | 3,381,326 Shares held | 10/16/2023 | View profile |
| MOATAZEDI DAVID See Remarks | ▼ Sell | Open Market | 499,592 Shares held | 9/2/2026 | View profile |
| Avelar Rui See Remarks | ▼ Sell | Open Market | 427,423 Shares held | 3/20/2026 | View profile |
| Malik Vikram Director | ▲ Buy | Grant | 321,109 Shares held | 2/17/2026 | View profile |
| Mitchell Tatjana Chief Financial Officer | ▲ Buy | Grant | 226,092 Shares held | 2/17/2026 | View profile |
| Beaver Sandra Chief Financial Officer | ▼ Sell | Open Market | 167,089 Shares held | 5/13/2025 | View profile |
| Lauren P. Silvernail See Remarks | ▼ Sell | Open Market | 141,571 Shares held | 5/18/2022 | View profile |
| Muilenburg Crystal Chief Marketing Officer | ▼ Sell | Open Market | 134,248 Shares held | 3/8/2022 | View profile |
| Stewart Brady Director | ▲ Buy | Grant | 134,188 Shares held | 2/17/2026 | View profile |
| Albert G. White III Director | ▲ Buy | Grant | 95,937 Shares held | 2/17/2026 | View profile |
| Yamagishi-Dressler Tomoko Chief Marketing Officer | ▼ Sell | Open Market | 89,949 Shares held | 8/22/2025 | View profile |
| GILL DAVID N Director | ▲ Buy | Grant | 86,887 Shares held | 2/17/2026 | View profile |
| Karah Herdman Parschauer EVP and General Counsel | ▲ Buy | Grant | 77,742 Shares held | 2/17/2026 | View profile |
| BLANK SIMONE Director | ▲ Buy | Grant | 77,111 Shares held | 3/7/2025 | View profile |
| HAYMAN ROBERT Director | ▲ Buy | Grant | 54,856 Shares held | 2/7/2024 | View profile |
| Peter C. Farrell Director | ▲ Buy | Grant | 43,174 Shares held | 1/27/2023 | View profile |
Transaction History
| MOATAZEDI DAVID | ▼ Sell | Open Market | 105,108 | $950K | 9/2/2026 |
| Avelar Rui | ▼ Sell | Open Market | 3,119 | $15K | 3/20/2026 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 13,669 | $65K | 3/20/2026 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 116,720 | $571K | 3/17/2026 |
| Avelar Rui | ▼ Sell | Open Market | 29,996 | $147K | 3/17/2026 |
| Avelar Rui | ▲ Buy | Option Exercise | 8,804 | $0 | 3/16/2026 |
| MOATAZEDI DAVID | ▲ Buy | Option Exercise | 67,489 | $0 | 3/16/2026 |
| Karah Herdman Parschauer | ▲ Buy | Grant | 45,559 | $0 | 2/17/2026 |
| Stewart Brady | ▲ Buy | Grant | 45,559 | $0 | 2/17/2026 |
| Mitchell Tatjana | ▲ Buy | Grant | 121,489 | $0 | 2/17/2026 |
| Albert G. White III | ▲ Buy | Grant | 45,559 | $0 | 2/17/2026 |
| MOATAZEDI DAVID | ▲ Buy | Grant | 313,212 | $0 | 2/17/2026 |
| Malik Vikram | ▲ Buy | Grant | 45,559 | $0 | 2/17/2026 |
| Avelar Rui | ▲ Buy | Grant | 94,913 | $0 | 2/17/2026 |
| GILL DAVID N | ▲ Buy | Grant | 45,559 | $0 | 2/17/2026 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 10,539 | $75K | 12/22/2025 |
| Avelar Rui | ▼ Sell | Open Market | 2,261 | $16K | 12/22/2025 |
| Mitchell Tatjana | ▲ Buy | Grant | 104,603 | $0 | 9/8/2025 |
| Yamagishi-Dressler Tomoko | ▼ Sell | Open Market | 5,722 | $43K | 8/22/2025 |
| Stewart Brady | ▲ Buy | Open Market | 30,000 | $204K | 8/15/2025 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 16,582 | $164K | 6/16/2025 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 111,323 | $1.1M | 6/13/2025 |
| Albert G. White III | ▲ Buy | Open Market | 20,000 | $189K | 6/9/2025 |
| Beaver Sandra | ▼ Sell | Open Market | 6,494 | $65K | 5/13/2025 |
| Avelar Rui | ▼ Sell | Open Market | 3,385 | $33K | 5/12/2025 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 15,787 | $156K | 5/12/2025 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 6,251 | $78K | 3/27/2025 |
| Avelar Rui | ▼ Sell | Open Market | 27,904 | $370K | 3/18/2025 |
| Beaver Sandra | ▼ Sell | Open Market | 8,996 | $119K | 3/18/2025 |
| Yamagishi-Dressler Tomoko | ▼ Sell | Open Market | 4,536 | $60K | 3/18/2025 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 103,376 | $1.4M | 3/18/2025 |
| Karah Herdman Parschauer | ▼ Sell | Open Market | 12,888 | $167K | 3/12/2025 |
| Yamagishi-Dressler Tomoko | ▲ Buy | Grant | 17,832 | $0 | 3/7/2025 |
| Beaver Sandra | ▲ Buy | Grant | 35,663 | $0 | 3/7/2025 |
| MOATAZEDI DAVID | ▲ Buy | Grant | 95,399 | $0 | 3/7/2025 |
| Avelar Rui | ▲ Buy | Grant | 23,776 | $0 | 3/7/2025 |
| BLANK SIMONE | ▲ Buy | Grant | 7,364 | $0 | 3/7/2025 |
| GILL DAVID N | ▲ Buy | Grant | 7,364 | $0 | 3/7/2025 |
| Stewart Brady | ▲ Buy | Grant | 7,364 | $0 | 3/7/2025 |
| Albert G. White III | ▲ Buy | Grant | 7,364 | $0 | 3/7/2025 |
| Malik Vikram | ▲ Buy | Grant | 7,364 | $0 | 3/7/2025 |
| Karah Herdman Parschauer | ▲ Buy | Grant | 7,364 | $0 | 3/7/2025 |
| Avelar Rui | ▼ Sell | Open Market | 2,252 | $24K | 12/23/2024 |
| Beaver Sandra | ▼ Sell | Open Market | 1,586 | $17K | 12/23/2024 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 10,502 | $114K | 12/23/2024 |
| Beaver Sandra | ▼ Sell | Open Market | 3,276 | $49K | 9/6/2024 |
| Yamagishi-Dressler Tomoko | ▼ Sell | Open Market | 5,631 | $89K | 8/30/2024 |
| Albert G. White III | ▲ Buy | Grant | 23,014 | $0 | 7/1/2024 |
| MOATAZEDI DAVID | ▲ Buy | Option Exercise | 175,940 | $1.3M | 6/6/2024 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 175,940 | $2.2M | 6/6/2024 |
| MOATAZEDI DAVID | ▲ Buy | Option Exercise | 155,278 | $848K | 6/5/2024 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 155,278 | $2.0M | 6/5/2024 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 140,214 | $1.8M | 6/4/2024 |
| Malik Vikram | ▼ Sell | Open Market | 7,500 | $97K | 6/3/2024 |
| GILL DAVID N | ▼ Sell | Open Market | 6,718 | $85K | 5/14/2024 |
| GILL DAVID N | ▼ Sell | Open Market | 3,643 | $46K | 5/13/2024 |
| Malik Vikram | ▼ Sell | Open Market | 28,000 | $362K | 5/13/2024 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 16,051 | $204K | 5/10/2024 |
| Avelar Rui | ▼ Sell | Open Market | 3,441 | $44K | 5/10/2024 |
| Beaver Sandra | ▼ Sell | Open Market | 2,423 | $31K | 5/10/2024 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 6,236 | $86K | 3/27/2024 |
| Avelar Rui | ▼ Sell | Open Market | 27,603 | $384K | 3/19/2024 |
| Beaver Sandra | ▼ Sell | Open Market | 5,672 | $79K | 3/19/2024 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 96,566 | $1.3M | 3/19/2024 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 7,706 | $101K | 2/22/2024 |
| Avelar Rui | ▼ Sell | Open Market | 1,821 | $24K | 2/22/2024 |
| Beaver Sandra | ▼ Sell | Open Market | 1,821 | $24K | 2/22/2024 |
| MOATAZEDI DAVID | ▲ Buy | Grant | 61,202 | $0 | 2/21/2024 |
| Avelar Rui | ▲ Buy | Grant | 13,115 | $0 | 2/21/2024 |
| Beaver Sandra | ▲ Buy | Grant | 13,115 | $0 | 2/21/2024 |
| BLANK SIMONE | ▲ Buy | Grant | 6,464 | $0 | 2/7/2024 |
| GILL DAVID N | ▲ Buy | Grant | 6,464 | $0 | 2/7/2024 |
| Stewart Brady | ▲ Buy | Grant | 6,464 | $0 | 2/7/2024 |
| HAYMAN ROBERT | ▲ Buy | Grant | 6,464 | $0 | 2/7/2024 |
| Karah Herdman Parschauer | ▲ Buy | Grant | 6,464 | $0 | 2/7/2024 |
| Malik Vikram | ▲ Buy | Grant | 6,464 | $0 | 2/7/2024 |
| Yamagishi-Dressler Tomoko | ▲ Buy | Grant | 24,648 | $0 | 2/7/2024 |
| Beaver Sandra | ▲ Buy | Grant | 35,211 | $0 | 2/7/2024 |
| Avelar Rui | ▲ Buy | Grant | 35,211 | $0 | 2/7/2024 |
| MOATAZEDI DAVID | ▲ Buy | Grant | 134,976 | $0 | 2/7/2024 |
| Karah Herdman Parschauer | ▼ Sell | Open Market | 11,931 | $157K | 1/30/2024 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 31,300 | $305K | 12/8/2023 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 51,348 | $518K | 12/6/2023 |
| Medytox Inc. | ▼ Sell | Open Market | 1,690,663 | $12.7M | 10/16/2023 |
| Beaver Sandra | ▼ Sell | Open Market | 3,178 | $31K | 9/6/2023 |
| Yamagishi-Dressler Tomoko | ▲ Buy | Grant | 63,358 | $0 | 8/21/2023 |
| Avelar Rui | ▼ Sell | Open Market | 2,211 | $23K | 8/16/2023 |
| Beaver Sandra | ▼ Sell | Open Market | 2,211 | $23K | 8/16/2023 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 14,778 | $152K | 8/16/2023 |
| Malik Vikram | ▲ Buy | Open Market | 174,967 | $1.3M | 8/15/2023 |
| Avelar Rui | ▲ Buy | Grant | 19,672 | $0 | 8/14/2023 |
| Beaver Sandra | ▲ Buy | Grant | 19,672 | $0 | 8/14/2023 |
| MOATAZEDI DAVID | ▲ Buy | Grant | 91,803 | $0 | 8/14/2023 |
| BLANK SIMONE | ▼ Sell | Other | 109 | $0 | 8/11/2023 |
| BLANK SIMONE | ▼ Sell | Other | 115,206 | $0 | 8/11/2023 |
| Malik Vikram | ▼ Sell | Other | 22,998 | $0 | 8/11/2023 |
| HAYMAN ROBERT | ▼ Sell | Other | 218 | $0 | 8/11/2023 |
| HAYMAN ROBERT | ▼ Sell | Other | 366 | $0 | 8/11/2023 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 6,110 | $52K | 3/27/2023 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 64,211 | $544K | 3/14/2023 |
| Avelar Rui | ▼ Sell | Open Market | 14,906 | $126K | 3/14/2023 |
| Alphaeon 1 LLC | ▼ Sell | Open Market | 1,850,000 | $15.5M | 2/17/2023 |
| Medytox Inc. | ▼ Sell | Open Market | 2,187,511 | $18.6M | 2/7/2023 |
| Stewart Brady | ▲ Buy | Grant | 8,293 | $0 | 1/27/2023 |
| HAYMAN ROBERT | ▲ Buy | Grant | 8,293 | $0 | 1/27/2023 |
| Malik Vikram | ▲ Buy | Grant | 8,293 | $0 | 1/27/2023 |
| Karah Herdman Parschauer | ▲ Buy | Grant | 8,293 | $0 | 1/27/2023 |
| BLANK SIMONE | ▲ Buy | Grant | 8,293 | $0 | 1/27/2023 |
| GILL DAVID N | ▲ Buy | Grant | 8,293 | $0 | 1/27/2023 |
| Peter C. Farrell | ▲ Buy | Grant | 8,293 | $0 | 1/27/2023 |
| Avelar Rui | ▲ Buy | Grant | 97,642 | $0 | 1/25/2023 |
| MOATAZEDI DAVID | ▲ Buy | Grant | 187,927 | $0 | 1/25/2023 |
| Beaver Sandra | ▲ Buy | Grant | 62,642 | $0 | 1/25/2023 |
| Medytox Inc. | ▼ Sell | Open Market | 37,043 | $409K | 1/20/2023 |
| Medytox Inc. | ▼ Sell | Open Market | 38,304 | $344K | 10/6/2022 |
| Medytox Inc. | ▼ Sell | Open Market | 6,848 | $61K | 10/5/2022 |
| Medytox Inc. | ▼ Sell | Open Market | 24,000 | $248K | 9/15/2022 |
| Medytox Inc. | ▼ Sell | Open Market | 73,000 | $750K | 9/14/2022 |
| HAYMAN ROBERT | ▲ Buy | Open Market | 1,091 | $12K | 9/12/2022 |
| HAYMAN ROBERT | ▲ Buy | Open Market | 8,909 | $92K | 9/9/2022 |
| Medytox Inc. | ▼ Sell | Open Market | 20,700 | $218K | 9/9/2022 |
| Medytox Inc. | ▼ Sell | Open Market | 15,300 | $159K | 9/8/2022 |
| HAYMAN ROBERT | ▲ Buy | Open Market | 4,967 | $50K | 9/7/2022 |
| BLANK SIMONE | ▲ Buy | Open Market | 20,000 | $185K | 9/6/2022 |
| Peter C. Farrell | ▲ Buy | Open Market | 10,000 | $91K | 9/6/2022 |
| Beaver Sandra | ▲ Buy | Grant | 36,443 | $0 | 9/5/2022 |
| Medytox Inc. | ▼ Sell | Open Market | 26,000 | $345K | 8/1/2022 |
| Lauren P. Silvernail | ▼ Sell | Open Market | 52,015 | $646K | 5/18/2022 |
| Lauren P. Silvernail | ▼ Sell | Open Market | 16,189 | $225K | 5/17/2022 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 55,321 | $754K | 5/16/2022 |
| GILL DAVID N | ▼ Sell | Open Market | 5,000 | $68K | 5/16/2022 |
| GILL DAVID N | ▼ Sell | Open Market | 5,313 | $70K | 5/13/2022 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 6,104 | $71K | 3/28/2022 |
| Muilenburg Crystal | ▼ Sell | Open Market | 6,495 | $63K | 3/8/2022 |
| MOATAZEDI DAVID | ▼ Sell | Open Market | 37,972 | $369K | 3/8/2022 |
| Avelar Rui | ▼ Sell | Open Market | 10,192 | $99K | 3/8/2022 |
| Lauren P. Silvernail | ▼ Sell | Open Market | 10,192 | $99K | 3/8/2022 |
| MOATAZEDI DAVID | ▲ Buy | Grant | 214,286 | $0 | 1/24/2022 |
| Lauren P. Silvernail | ▲ Buy | Grant | 53,571 | $0 | 1/24/2022 |
| Avelar Rui | ▲ Buy | Grant | 53,571 | $0 | 1/24/2022 |
| Muilenburg Crystal | ▲ Buy | Grant | 50,000 | $0 | 1/24/2022 |
| Malik Vikram | ▲ Buy | Grant | 15,568 | $0 | 1/24/2022 |
| Karah Herdman Parschauer | ▲ Buy | Grant | 15,568 | $0 | 1/24/2022 |
| GILL DAVID N | ▲ Buy | Grant | 15,568 | $0 | 1/24/2022 |
| Peter C. Farrell | ▲ Buy | Grant | 15,568 | $0 | 1/24/2022 |
| HAYMAN ROBERT | ▲ Buy | Grant | 15,568 | $0 | 1/24/2022 |
| BLANK SIMONE | ▲ Buy | Grant | 15,568 | $0 | 1/24/2022 |
| Stewart Brady | ▲ Buy | Grant | 36,508 | $0 | 1/5/2022 |
| Alphaeon 1 LLC | ▼ Sell | Open Market | 2,597,475 | $24.7M | 9/2/2021 |
| Medytox Inc. | ▲ Buy | Open Market | 51,000 | $558K | 8/27/2021 |
| Medytox Inc. | ▲ Buy | Open Market | 66,000 | $727K | 8/26/2021 |
| Medytox Inc. | ▲ Buy | Open Market | 44,000 | $489K | 8/25/2021 |
| Medytox Inc. | ▲ Buy | Open Market | 72,219 | $807K | 8/24/2021 |
| Malik Vikram | ▼ Sell | Open Market | 26,077 | $287K | 8/23/2021 |
| Medytox Inc. | ▲ Buy | Open Market | 69,781 | $770K | 8/23/2021 |
| Medytox Inc. | ▲ Buy | Open Market | 48,000 | $507K | 8/20/2021 |
| Medytox Inc. | ▲ Buy | Open Market | 55,000 | $578K | 8/19/2021 |
| Medytox Inc. | ▲ Buy | Open Market | 14,043 | $156K | 8/13/2021 |
| Medytox Inc. | ▲ Buy | Open Market | 23,000 | $253K | 8/12/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Evolus (EOLS) Passes Momentum Screens
Evolus Inc. has recently met the criteria for the Minervini Trend Template and a high growth momentum screen. This suggests the stock is showing signs of upward price strength and volume activity. While the company trades well below its average analyst target price, these technical signals indicate a shift in trading patterns.
Evolus (EOLS) Passes Momentum Screens. Evolus Inc. has recently met the criteria for the Minervini Trend Template and a high growth momentum screen. This suggests the stock is showing signs of upward price strength and volume activity. While the company trades well below its average analyst target price, these technical signals indicate a shift in trading patterns.